Wright Investors Service Inc. trimmed its position in shares of Aetna Inc (NYSE:AET) by 31.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,751 shares of the company’s stock after selling 9,187 shares during the period. Aetna makes up approximately 1.2% of Wright Investors Service Inc.’s holdings, making the stock its 24th biggest holding. Wright Investors Service Inc.’s holdings in Aetna were worth $3,563,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Wells Fargo & Company MN raised its holdings in Aetna by 4.2% during the 3rd quarter. Wells Fargo & Company MN now owns 1,365,596 shares of the company’s stock valued at $217,144,000 after buying an additional 54,928 shares during the period. Fayez Sarofim & Co. raised its holdings in Aetna by 82.8% during the 3rd quarter. Fayez Sarofim & Co. now owns 7,427 shares of the company’s stock valued at $1,181,000 after buying an additional 3,365 shares during the period. California Public Employees Retirement System raised its holdings in Aetna by 9.4% during the 3rd quarter. California Public Employees Retirement System now owns 910,189 shares of the company’s stock valued at $144,729,000 after buying an additional 78,363 shares during the period. Prudential Financial Inc. raised its holdings in Aetna by 3.6% during the 3rd quarter. Prudential Financial Inc. now owns 1,089,269 shares of the company’s stock valued at $173,205,000 after buying an additional 38,223 shares during the period. Finally, Commonwealth Bank of Australia raised its holdings in Aetna by 2.9% during the 3rd quarter. Commonwealth Bank of Australia now owns 45,887 shares of the company’s stock valued at $7,290,000 after buying an additional 1,291 shares during the period. 87.10% of the stock is currently owned by institutional investors and hedge funds.
Aetna Inc (NYSE:AET) traded down $1.53 on Wednesday, hitting $176.99. The stock had a trading volume of 1,370,811 shares, compared to its average volume of 2,916,720. Aetna Inc has a fifty-two week low of $124.83 and a fifty-two week high of $194.40. The company has a quick ratio of 0.53, a current ratio of 1.68 and a debt-to-equity ratio of 0.52. The company has a market cap of $57,993.06, a P/E ratio of 30.81, a price-to-earnings-growth ratio of 1.44 and a beta of 0.60.
Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, January 30th. The company reported $1.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.07. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The business had revenue of $14.74 billion for the quarter, compared to the consensus estimate of $14.79 billion. During the same quarter in the prior year, the company earned $0.08 EPS. The business’s revenue was down 6.2% compared to the same quarter last year. equities analysts forecast that Aetna Inc will post 10.99 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Thursday, January 11th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date was Wednesday, January 10th. Aetna’s payout ratio is 34.78%.
AET has been the topic of several recent research reports. ValuEngine upgraded Aetna from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Piper Jaffray Companies upgraded Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price target on the stock in a report on Wednesday, January 3rd. Argus lowered Aetna from a “buy” rating to a “hold” rating and set a $185.00 price target on the stock. in a report on Wednesday, December 6th. Morgan Stanley lowered Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 target price on the stock. in a research note on Wednesday, December 20th. Finally, Jefferies Group increased their target price on Aetna from $165.00 to $185.00 and gave the stock a “hold” rating in a research note on Wednesday, November 1st. Ten research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Aetna currently has an average rating of “Buy” and an average target price of $185.94.
ILLEGAL ACTIVITY NOTICE: This piece was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another publication, it was copied illegally and republished in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/02/14/wright-investors-service-inc-reduces-stake-in-aetna-inc-aet.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.